Thomas Leung

2021

In 2021, Thomas Leung earned a total compensation of $500.6K as Former Chief Financial Officer at Avalanche Biotechnologies, a 74% decrease compared to previous year.

Compensation breakdown

Option Awards$156,029
Salary$38,652
Other$305,876
Total$500,557

Leung received $305.9K in other compensation, accounting for 61% of the total pay in 2021.

Leung also received $156K in option awards and $38.7K in salary.

Rankings

In 2021, Thomas Leung's compensation ranked 10,720th out of 12,415 executives tracked by ExecPay. In other words, Leung earned more than 13.7% of executives.

ClassificationRankingPercentile
All
10,720
out of 12,415
14th
Division
Manufacturing
4,728
out of 5,505
14th
Major group
Chemicals And Allied Products
2,124
out of 2,375
11th
Industry group
Drugs
1,887
out of 2,096
10th
Industry
Biological Products, Except Diagnostic Substances
415
out of 449
8th

Pay ratio

Thomas Leung's Pay$500,557
Median Employee's Pay$188,229
Pay Ratio

3

to 1

In 2021, the annual total compensation of Thomas Leung was $500,557.

The annual total compensation of the median employee at Avalanche Biotechnologies was $188,229.

The ratio of Thomas Leung's pay to the pay of median employee was therefore 3 to one.

Source: SEC filing on April 26, 2022.

Leung's colleagues

We found nine more compensation records of executives who worked with Thomas Leung at Avalanche Biotechnologies in 2021.

2021

Laurent Fischer

Avalanche Biotechnologies

Chief Executive Officer

2021

Christopher DeRespino

Avalanche Biotechnologies

Chief Financial Officer

2021

Angela Thedinga

Avalanche Biotechnologies

Chief Technology Officer

2021

Leone Patterson

Avalanche Biotechnologies

Chief Financial Officer

2021

Kishor Soparkar

Avalanche Biotechnologies

Chief Operating Officer

2021

Julie Clark

Avalanche Biotechnologies

Chief Medical Officer

2021

Brigit Riley

Avalanche Biotechnologies

Chief Scientific Officer

2021

Rupert D'Souza

Avalanche Biotechnologies

Chief Financial Officer

2021

Jack Thrift

Avalanche Biotechnologies

Chief Financial Officer

News

You may also like